These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta. Cumberbatch M; Dearman RJ; Kimber I Immunology; 2002 Apr; 105(4):466-77. PubMed ID: 11985667 [TBL] [Abstract][Full Text] [Related]
27. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576 [TBL] [Abstract][Full Text] [Related]
28. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells. Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800 [TBL] [Abstract][Full Text] [Related]
29. Presentation of antigen to suppressor cells by a dimethylbenz (a) anthracene-resistant, Ia-positive, Thy-1-negative, I-J-restricted epidermal cell. Halliday GM; Wood RC; Muller HK Immunology; 1990 Jan; 69(1):97-103. PubMed ID: 1968886 [TBL] [Abstract][Full Text] [Related]
30. Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells. Aberer W; Romani N; Elbe A; Stingl G J Immunol; 1986 Feb; 136(4):1210-6. PubMed ID: 2868057 [TBL] [Abstract][Full Text] [Related]
32. Expression of the Ly-5 alloantigenic system on epidermal cells. Leibl H; Hutterer J; Korschan H; Schuler G; Tani M; Tschachler E; Romani N; Wolff K; Stingl G J Invest Dermatol; 1985 Feb; 84(2):91-5. PubMed ID: 2857189 [TBL] [Abstract][Full Text] [Related]
33. Topical and oral retinoids protect Langerhans' cells and epidermal Thy-1+ dendritic cells from being depleted by ultraviolet radiation. Ho KK; Halliday GM; Barnetson RS Immunology; 1991 Nov; 74(3):425-31. PubMed ID: 1685145 [TBL] [Abstract][Full Text] [Related]
34. Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity. Rheins LA; Nordlund JJ J Immunol; 1986 Feb; 136(3):867-76. PubMed ID: 3079801 [TBL] [Abstract][Full Text] [Related]
35. Thy-1 antigen-bearing dendritic cells in murine epidermis are derived from bone marrow precursors. Bergstresser PR; Tigelaar RE; Streilein JW J Invest Dermatol; 1984 Aug; 83(2):83-7. PubMed ID: 6147381 [TBL] [Abstract][Full Text] [Related]
37. In vivo activation of langerhans cells and dendritic epidermal T cells in the elicitation phase of murine contact hypersensitivity. Tsuruta D; Kaneda K; Teramae H; Ishii M Br J Dermatol; 1999 Mar; 140(3):392-9. PubMed ID: 10233256 [TBL] [Abstract][Full Text] [Related]
38. DNFB contact sensitivity (CS) in BALB/c and C3H/He mice: requirement for early-occurring, early-acting, antigen-specific, CS-initiating cells with an unusual phenotype (Thy-1+, CD5+, CD3-, CD4-, CD8-, sIg-, B220+, MHC class II-, CD23+, IL-2R-, IL-3R+, Mel-14-, Pgp-1+, J11d+, MAC-1+, LFA-1+, and Fc gamma RII+). Ishii N; Takahashi K; Nakajima H; Tanaka S; Askenase PW J Invest Dermatol; 1994 Mar; 102(3):321-7. PubMed ID: 7509836 [TBL] [Abstract][Full Text] [Related]
39. Pentamidine isethionate reduces Ia expression and antigen presentation by Langerhans cells and inhibits the contact hypersensitivity reaction. Blaylock BL; Kouchi Y; Comment CE; Corsini E; Rosenthal GJ; Luster MI J Immunol; 1991 Oct; 147(7):2116-21. PubMed ID: 1833452 [TBL] [Abstract][Full Text] [Related]
40. Alterations in Langerhans cells and Thy-1+ dendritic epidermal cells in murine epidermis during the evolution of ultraviolet radiation-induced skin cancers. Alcalay J; Craig JN; Kripke ML Cancer Res; 1989 Aug; 49(16):4591-6. PubMed ID: 2568173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]